Budget
- 250.000 euro for all Romanian partners in case a Romanian institution is the Coordinator; - 200.000 for all Romanian partners in case a Romanian institution is not the Coordinator;
Key dates and deadline
13 October 2025 Publication of Pre-announcement Trials4Health call 6 November 2025 Publication of Trials4Health call 13 November 2025 (14:30-16:30 CET) Webinar Infoday 30 November 2025 Deadline for contacting ECRIN representatives (additional budget request) 27 January 2026 Deadline for pre-proposal submission 17 April 2026 Communication of the results of the pre-proposal assessment (invitation for full proposal) 17 June 2026 Deadline for full proposal submission 24 August – 4 September 2026 Rebuttal stage End of October 2026 Communication of the funding decisions to the applicants January – May 2027 Expected project start (subject to national procedures)
Details
The aims of the call are: to support randomised interventional multi-country Investigator-Initiated Clinical Studies that are designed as pragmatic comparative-effectiveness studies and/or drug repurposing studies. The clinical trial design should be appropriate to answer the research question, and its selection shall be fully justified in the proposal. To exclude clinical studies with direct commercial purposes, the protocol and study design must be described in a very clear and transparent manner. to encourage and enable transnational collaboration between clinical/public health research teams (from hospital/ public health, healthcare settings and other healthcare organisations) that conduct multi-country IICS, either comparative-effectiveness or drug repurposing studies. The funding organisation responsible in Romania is UEFISCDI.
Eligibility
Eligible entities for funding are universities, public institutions, R&D national institutions, joint-stock companies, SME’s and Large companies, NGOs (associations, foundations, etc.), others. For UEFISCDI, both options are theoretically possible: - All participating organisations will be granted and should be part of the clinical study consortium. A maximum of 3 partners are authorised. - Or only one organisation will be granted and this organisation will establish a collaboration with other recruitment sites via subcontracting or a collaboration agreement Please contact the UEFISCDI NCP for a detailed clarification which approach would be the most appropriate for your proposal.
Additional information
The duration of the clinical studies will be 48 months. Any IICS must clearly demonstrate the potential health, economic, and/or policy impacts, as well as the added value of transnational collaboration. Applicants shall not apply to different calls for the same research activities. Double funding is not allowed. Proposals should follow the principles of Responsible Research and Innovation (RRI). Consortia must show how they will engage with and address the relevant social, political, equity, environmental or cultural dimensions of the proposed research. The proposal template and ERA4Health RRI Guidelines further elaborate on how RRI dimensions can be approached (see our recommendation in the guidelines for applicants). IICS supported by ERA4Health must respect fundamental ethical principles.
How to apply?
https://era4health.eu/calls/trials4health2026.php